purpleDx Pulmonary Disease Smartphone App Set for Release
electronRx announced it will launch purpleDx, a smartphone app for cardiopulmonary assessment, at CES 2025.
Read MorePosted by Chris Wolski | Dec 23, 2024 | Flu & Respiratory Infections |
electronRx announced it will launch purpleDx, a smartphone app for cardiopulmonary assessment, at CES 2025.
Read MorePosted by Chris Wolski | Dec 19, 2024 | Molecular Diagnostics |
Hologic, Inc. has partnered with the CDC to develop analyte specific reagents (ASRs) to detect H5N1 bird flu.
Read MorePosted by Andy Lundin | Dec 17, 2024 | Point-of-Care |
A new nanobody-based immunosensor is capable of stable operation in undiluted biological fluids with promising applications in POC testing.
Read MorePosted by Andy Lundin | Dec 17, 2024 | Emerging & Zoonotic Diseases, Point-of-Care |
Labcorp introduced a molecular H5 bird flu test to help diagnose human infections with the H5N1 virus, enhancing public health response.
Read MorePosted by Andy Lundin | Dec 16, 2024 | Covid 19, Immunoassay Reagents & test Kits |
The TaqPath COVID-19 Diagnostic PCR Kit enables labs to adopt a validated in vitro diagnostic workflow for SARS-CoV-2 detection.
Read More